Replies to post #5694 on Galena Biopharma fka GALE

[MDMSCF]

The phase 2 data on NeuVax is very convincing! My models estimate full enrollment will happen around October and possible interim results March 2015. The NeuVax/Herceptin data is also impressive and if the combo also works in Her2 3+ then NeuVax would have a large market opp.

It really comes down to who you believe. The data and Dr. Mittendorf or lying scum political science major AF.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428069/pdf/nihms385833.pdf